Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Accuracy of cuffless blood pressure monitoring during antihypertensive therapy
jRCTs051250220Active, not recruiting
- Sponsor
- Arblet
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of indapamide and amlodipine in essential hypertension (2 arms), sponsored by Arblet. Started Feb 2026; status: active, not recruiting.
02
Drugs
indapamideamlodipine
03
Conditions
essential hypertension
Beyond the preview
Go deeper on jRCTs051250220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051250220.